At the same time, we verified that the expression levels of eIF4E were significantly related to immune cell markers in the same BRCA patients, including those for TAMs (IL10), M2 macrophages (CD163), Th1 cells (STAT1), Th2 cells (GATA3, STAT6), Th17 cells (STAT3) and Tregs (STAT5B). This evidence concerns the gene EIF4E and invasive breast carcinoma.